Cytek Biosciences Inc (CTKB) Reports Robust Revenue Growth and Positive Net Income in Q4 2023 [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
Operating Expenses : Q4 operating expenses rose by 12% due to the Luminex acquisition and increased headcount. Net Income : Q4 net income improved to $6.3 million, up from $3.7 million in the same quarter last year. Full Year Performance : 2023 full year revenue grew by 18% to $193.4 million, with a net loss of $11.3 million. 2024 Outlook : Cytek anticipates revenue between $203 million and $213 million, with positive net income expected. Warning! GuruFocus has detected 7 Warning Signs with MTZ. On March 1, 2024, Cytek Biosciences Inc ( NASDAQ:CTKB ) released its 8-K filing , detailing the financial results for the fourth quarter and full year of 2023 and providing an outlook for 2024. The company, known for its advanced cell analysis solutions, including the Aurora and Northern Lights systems, continues to innovate in the medical devices and instruments industry. Fourth Quarter Financial Highlights Cytek Biosciences reported a 21% increase in total revenue for Q4 2023,
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe [Yahoo! Finance]Yahoo! Finance
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeGlobeNewswire
- Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024GlobeNewswire
- Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]Yahoo! Finance
CTKB
Earnings
- 11/7/23 - Miss
CTKB
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- CTKB's page on the SEC website